Cowen & Company Initiates Heron Therapeutics With Outperform

Monica Gerson , Benzinga Staff Writer

June 26, 2015 9:24am Comments

Analysts at Cowen & Company initiated coverage on Heron Therapeutics Inc (NASDAQ: HRTX) with a Outperform rating.

The target price for Heron Therapeutics is set to $40.

Heron Therapeutics' shares rose 3.33 percent to $30.37 in pre-market trading.

Date	Firm	Action	To
Dec 2020	SVB Leerink	Maintains	Outperform
May 2020	Guggenheim	Initiates Coverage On	Buy
Mar 2020	Needham	Maintains	Buy

Posted-In: Cowen & Company Initiation Analyst Ratings

Need analyst data?
Click here to see licensing options.

Stock	Firm	Action	PT
SEDG	B of A Securities	Maintains	411.0
PTLO	Piper Sandler	Maintains	28.0
AOUT	Lake Street	Maintains	26.0
RAPT	Piper Sandler	Maintains	52.0
OCX	Lake Street	Maintains	6.0

1	PONY, WRD: Pony AI Vs. WeRide: Who's Leading China's Robotaxi Race
2	CMG: Stock Of The Day: Time To Buy Chipotle Mexican Grill?
3	PLTR, SPY: Palantir's Next Stop Is $200, Says Jim Cramer As PLTR...
4	F, GM: Trump Tariff Worries Drive Middle-Income Americans To...
5	CRI, PSX: S&P 500 Notches 5th Consecutive Record Clo...
6	Trump's Charm Offense In Europe Unleashes...
7	$DOGE, $ETH: Bitcoin, Ethereum, Dogecoin Climb O...

1	SRPT: FDA Lifts Safety Hold On Sarepta's Muscular Dystrophy Gene Therapy—Wa...
2	BA, CZR: AMD Rises To 1-Year Highs, Crude Eyes $68: What's Moving Markets...
3	PONY: Pony AI Stock Dips Despite Major Shanghai Robotaxi Permit
4	$JUP, SOL: Kuvi.ai Raises $700,000 Seed Round To Launch Private Bet...
5	TSLA, XIACY: Li Auto Debuts Li i8 Electric SUV With Ultra-...
6	NEGG, PET: 12 Consumer Discretionary Stocks Mov...
7	EKSO, NEO: 12 Health Care Stocks Movin...

Market Overview